Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study.

Sehouli, Jalid; Camara, O; Schmidt, M; Mahner, S; Seipelt, G; Otremba, B; Schmalfeldt, B; Tesch, H; Lorenz-Schlüter, C; Oskay-Ozcelik, G

Sehouli, Jalid; Camara, O; Schmidt, M; Mahner, S; Seipelt, G; Otremba, B; Schmalfeldt, B; Tesch, H; Lorenz-Schlüter, C; Oskay-Ozcelik, G.

Affiliation

Sehouli J; Department of Gynecology and Obstetrics, Charité Campus Virchow-Klinikum, University Medicine Berlin, Berlin, Germany. sehouli@aol.com

Cancer Chemother Pharmacol ; 64(3): 585-91, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19156414

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Doxorubicin/analogs & derivatives; Ovarian Neoplasms/drug therapy; Polyethylene Glycols/therapeutic use; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic/administration & dosage; Antibiotics, Antineoplastic/adverse effects; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Doxorubicin/therapeutic use; Female; Germany/epidemiology; Humans; Middle Aged; Neoplasm Recurrence, Local; Polyethylene Glycols/administration & dosage; Polyethylene Glycols/adverse effects; Remission Induction/methods; Survival Rate; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Polyethylene Glycols / Doxorubicin / Antibiotics, Antineoplastic Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Cancer Chemother Pharmacol Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google